Cancer biotech CARGO Therapeutics (CRGX) priced its IPO at $15.00 – the low end of the $15.00-to-$17.00 price range – on Thursday night, Nov. 9, 2023. The cancer cell therapy company priced 18.75 million shares – the number of shares in the prospectus – at $15.00 to raise $281.25 million. That’s $18.75 million less than […]
November 9, 2023 Read MoreSPACs grabbed the early November spotlight. Two SPAC IPOs raised a combined $361.5 million on Wednesday night (Nov. 8, 2023): AI Transportation Acquisition Corp. (AITRU) upsized its SPAC IPO at pricing to 6.15 million units – up from 5.0 million units in the prospectus – and priced the deal at $10.00, as expected, to raise […]
Read MorePhase 2 cancer clinical biotech CARGO Therapeutics (CRGX proposed) launched its $300 million IPO early today (Monday, Nov. 6, 2023) by disclosing terms: 18.75 million shares at $15.00 to $17.00. The IPO is expected to price Thursday night, Nov. 9, 2023, to trade Friday, Nov. 10, on the NASDAQ. If CARGO Therapeutics prices its IPO […]
November 6, 2023 Read MoreGene therapy startup Lexeo Therapeutics (LXEO) priced its IPO at $11.00 – $2.00 below the low end of its $13.00-to-$15.00 range – on Thursday night, Nov. 2, 2023. Lexeo Therapeutics slightly increased the number of shares to 9.09 million – up from 9.0 million in the prospectus – to raise $100.0 million. The deal raised […]
November 2, 2023 Read MoreBermuda-based Hamilton Insurance Group, Ltd. (HG proposed) launched its $255 million IPO early today (Wednesday, Nov. 1, 2023) by disclosing terms: 15.0 million Class B common shares at $16.00 to $18.00. (Source: S-1/A filing dated Nov. 1, 2023) The IPO is scheduled for pricing next week – on Thursday night, Nov. 9, to trade Friday, […]
November 1, 2023 Read MoreAlpha Technology Group Ltd. (ATGL) opened flat at $4.00 – its IPO price – at 10:45 a.m. EDT today and quickly rose to $4.54 in its NASDAQ debut on Halloween (Tuesday, Oct. 31, 2023). Before noon EDT, Alpha Technology Group’s stock popped above $5.00. At around 12:34 p.m. EDT, the stock hit $6.54 – its session […]
October 31, 2023 Read MoreBiotech Lexeo Therapeutics (LXEO proposed) launched its $126 million IPO today -Monday, Oct. 30, 2023 – for pricing this week. Lexeo Therapeutics disclosed its IPO terms – 9.0 million shares at $13.00 to $15.00 – in an S-1/A filing early today. The news injected some life – and the only $100-million-plus IPO – into the […]
October 30, 2023 Read MoreMach Natural Resources LP (MNR), an Oklahoma City-based oil and natural gas partnership, priced its IPO at $19.00 – the low end of its $19.00-to-$21.00 range – on Tuesday night (Oct. 24, 2023). The profitable oil and gas drilling company priced 10 million units – the same number in the prospectus – at $19.00 to raise […]
October 24, 2023 Read MoreOklahoma City-based Mach Natural Resources LP (MNR proposed), an oil and natural gas limited partnership, is the featured attraction this week. Mach is the only big traditional deal on the IPO Calendar for the week of Oct. 23, 2023. Mach is offering 10 million common units at $19.00 to $21.00 to raise $200 million – […]
October 23, 2023 Read MoreFrench biotech Abivax S.A. (ABVX) priced its NASDAQ uplisting – a U.S. public offering of 18.7 million American Depositary Shares (ADS) – at $11.60 – the low end of its range – to raise $216.91 million on Thursday night (Oct. 19, 2023). The price range was $11.60 to $13.00 for the ADS. Abivax S.A.’s ADS […]
October 20, 2023 Read More